GEHC
GE HealthCare Technologies Inc.
$64.67
0.00%
$29.4B
No data for this timeframe.
Vol
Market Cap$29.4B
Cap SizeLarge Cap
Analyst ConsensusBuy (67%)
Inst. Holders9 funds
Inst. Value$9.1B
Inst. Activity1 buys / 0 sells
Insider Activity8B / 0S
Insider Net $$6.4M
Reddit Sentiment63° Warm
SEC Reports6
Congressional3 trades
Exchange Nasdaq·Sector X-Ray Apparatus & Tubes & Related Irradiation Apparatus·Inc. DE·CIK 0001932393·Prev Close $64.67
Recent Activity
Jun 8, 2026
short_volume
Short Volume: GEHC — 65.5% short (1.4M / 2.1M)
Short: 1,353,718 | Exempt: 898 | TRF Vol: 2,065,798 | Short Ratio: 65.5% | Off-exchange volume (dark
May 22, 2026
Insider
Lobo Kevin bought 10,000 shares
Director @ $64.18 ($641.8K)
May 19, 2026
SEC
Two independent directors made modest open-market purchases totaling $163K in GEHC, while the CEO of Patient Care Soluti
CLUSTER — Impact 2/10
May 15, 2026
Insider
Rackliffe Philip sold 16,458 shares
CEO, AIS @ $0.00 ($0.00)
May 15, 2026
Insider
Bankes Jeannette sold 5,535 shares
CEO, Patient Care Solutions @ $62.67 ($346.9K)
May 12, 2026
SEC
GE HealthCare insiders, including director H. Lawrence Culp Jr. ($5.0M), CEO Peter Arduini ($250K), and CFO James Saccar
CLUSTER — Impact 4/10
May 11, 2026
SEC
GE HealthCare filed an 8-K reporting the results of its May 7, 2026 annual shareholder meeting and two board committee a
8-K — Impact 2/10
Inst.
NORGES BANK — NEW
7,266,808 shares ($596.0M)
Price Targets
$79.72
+20.8% upside
Strong Buy
Current $66.01
Low $65.00
Median $80.00
High $98.00
18 analysts
$65.00
$98.00
Analyst Ratings
8Strong Buy
10Buy
9Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 21, 2026 | UBS | UPGRADE | Sell → Neutral |
| Apr 30, 2026 | JP Morgan | MAINTAIN | Neutral → Neutral |
| Apr 30, 2026 | Citigroup | MAINTAIN | Neutral → Neutral |
| Apr 30, 2026 | Goldman Sachs | DOWNGRADE | Buy → Neutral |
| Apr 30, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.03 ▼ -6.4% | $1.01 — $1.05 | -3% YoY | 14 |
| Next Q | $1.24 | $1.19 — $1.30 | 16% YoY | 14 |
| Current FY | $4.87 ▼ -2.2% | $4.69 — $4.96 | 6% YoY | 19 |
| Next FY | $5.37 ▼ -2.3% | $4.56 — $5.62 | 10% YoY | 19 |
Latest Reports
NEUTRAL
CLUSTER
2/10
Two independent directors made modest open-market purchases totaling $163K in GEHC, while the CEO of Patient Care Soluti
May 19, 2026
NEUTRAL
CLUSTER
4/10
GE HealthCare insiders, including director H. Lawrence Culp Jr. ($5.0M), CEO Peter Arduini ($250K), and CFO James Saccar
May 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $4.3B | — |
| DODGE & COX | $2.6B | ADD |
| NORGES BANK | $596.0M | NEW |
| MORGAN STANLEY | $564.9M | ADD |
| BANK OF AMERICA CORP | $360.8M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 22, 2026 | Lobo Kevin | BUY | $641.8K |
| May 15, 2026 | Rackliffe Philip | A | $0.00 |
| May 15, 2026 | Bankes Jeannette | F | $346.9K |
| May 12, 2026 | Hochman Rodney | BUY | $100.4K |
| May 8, 2026 | Yang Watkin | BUY | $63.0K |
Reddit Sentiment
63°
Warm
Bearish
Neutral
Bullish
Congressional Trades
3 members: 1 buys, 2 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Ro Khanna | D | BUY | $1,001 - $15,000 |
| Terri Sewell | D | SELL | $1,001 - $15,000 |
| Warren Davidson | R | SELL | $1,001 - $15,000 |
9 institutional holders with $9.1B total value (110,723,754 shares) as of 2025-Q4. Top holders: VANGUARD, DODGE, NORGES. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 52,275,767 | $4.3B | 47.2% | — |
| 2 | DODGE & COX | 31,211,229 | $2.6B | 28.2% | ADD +42.1% |
| 3 | NORGES BANK | 7,266,808 | $596.0M | 6.6% | NEW |
| 4 | MORGAN STANLEY | 6,887,643 | $564.9M | 6.2% | ADD +30.7% |
| 5 | BANK OF AMERICA CORP /DE/ | 4,399,224 | $360.8M | 4.0% | ADD +35.4% |
| 6 | FMR LLC | 3,351,797 | $274.9M | 3.0% | ADD +28.4% |
| 7 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,955,709 | $242.4M | 2.7% | NEW |
| 8 | WELLS FARGO & COMPANY/MN | 1,357,689 | $111.4M | 1.2% | ADD +28.2% |
| 9 | SOUND SHORE MANAGEMENT INC /CT/ | 1,017,888 | $83.5M | 0.9% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 7,266,808 | — | $596.0M | 2025-Q4 |
| UBS Group AG | TRIM | 3,038,335 | 1,876,118 | -38.3% | $140.9M | 2025-Q3 |
| NORGES BANK | EXIT | 6,319,974 | 0 | -100.0% | $0.00 | 2025-Q3 |
| DODGE & COX | ADD | 16,585,509 | 23,567,950 | +42.1% | $1.7B | 2025-Q2 |
| NORGES BANK | NEW | — | 6,319,974 | — | $468.1M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 3,333,290 | 4,514,903 | +35.4% | $334.4M | 2025-Q2 |
| FMR LLC | ADD | 2,144,681 | 2,753,492 | +28.4% | $204.0M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 392,600 | 0 | -100.0% | $0.00 | 2025-Q2 |
| CITADEL ADVISORS LLC | DOUBLED | 1,429,768 | 9,035,540 | +532.0% | $729.3M | 2025-Q1 |
| MORGAN STANLEY | ADD | 4,933,068 | 6,447,253 | +30.7% | $520.4M | 2025-Q1 |
| UBS Group AG | TRIM | 5,427,249 | 2,858,601 | -47.3% | $230.7M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | ADD | 1,165,035 | 1,494,153 | +28.2% | $120.6M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 392,600 | — | $31.7M | 2025-Q1 |
| NORGES BANK | EXIT | 6,248,800 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | ADD | 3,246,059 | 5,427,249 | +67.2% | $424.3M | 2024-Q4 |
| CITADEL ADVISORS LLC | TRIM | 5,320,969 | 1,429,768 | -73.1% | $111.8M | 2024-Q4 |
| Cullen Capital Management, LLC | EXIT | 2,183 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 2,710,938 | — | $254.4M | 2024-Q3 |
17 unique insiders with 8 transactions. Net insider value: $6.4M ($6.4M bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 22, 2026 | Lobo Kevin | Director | BUY | 10,000 | $64.18 | $641.8K |
| May 15, 2026 | Rackliffe Philip | CEO, AIS | A | 16,458 | $0.00 | $0.00 |
| May 15, 2026 | Bankes Jeannette | CEO, Patient Care Solutions | F | 5,535 | $62.67 | $346.9K |
| May 12, 2026 | Hochman Rodney F | Director | BUY | 1,618 | $62.03 | $100.4K |
| May 8, 2026 | Yang Watkin Phoebe L. | Director | BUY | 1,000 | $63.01 | $63.0K |
| May 7, 2026 | Stromberg William J | Director | A | 3,586 | $0.00 | $0.00 |
| May 7, 2026 | Madden Anne T | Director | A | 3,586 | $0.00 | $0.00 |
| May 7, 2026 | Lobo Kevin | Director | A | 3,586 | $0.00 | $0.00 |
| May 7, 2026 | LESJAK CATHERINE A | Director | A | 3,586 | $0.00 | $0.00 |
| May 7, 2026 | Hochman Rodney F | Director | A | 3,586 | $0.00 | $0.00 |
| May 7, 2026 | CULP H LAWRENCE JR | Director | A | 3,586 | $0.00 | $0.00 |
| May 7, 2026 | Yang Watkin Phoebe L. | Director | A | 3,586 | $0.00 | $0.00 |
| May 6, 2026 | Stromberg William J | Director | BUY | 1,000 | $61.69 | $61.7K |
| May 6, 2026 | CULP H LAWRENCE JR | Director | BUY | 80,805 | $61.88 | $5.0M |
| May 1, 2026 | SACCARO JAMES | Chief Financial Officer | BUY | 3,310 | $60.60 | $200.6K |
| Apr 30, 2026 | Arduini Peter J | President and CEO | BUY | 4,169 | $59.93 | $249.8K |
| Apr 30, 2026 | Jimenez Frank R | GC & Corporate Secretary | BUY | 1,750 | $60.45 | $105.8K |
| Mar 13, 2026 | Lobo Kevin | Director | A | 777 | $0.00 | $0.00 |
| Mar 2, 2026 | Rackliffe Philip | CEO, AVS | A | 24,598 | $0.00 | $0.00 |
| Mar 2, 2026 | Holton Adam Y | Chief People Officer | A | 5,457 | $0.00 | $0.00 |
| Mar 2, 2026 | Holton Adam Y | Chief People Officer | A | 14,348 | $0.00 | $0.00 |
| Mar 2, 2026 | Kass-Hout Taha | Chief Technology Officer | A | 13,254 | $0.00 | $0.00 |
| Mar 2, 2026 | Rott Roland | CEO, Imaging | A | 8,576 | $0.00 | $0.00 |
| Mar 2, 2026 | Rott Roland | CEO, Imaging | A | 22,548 | $0.00 | $0.00 |
| Mar 2, 2026 | Newcomb George A. | Chief Accounting Officer | A | 3,443 | $0.00 | $0.00 |
| Mar 2, 2026 | O'Neill Kevin Michael | CEO, PDx | A | 6,549 | $0.00 | $0.00 |
| Mar 2, 2026 | Bankes Jeannette | CEO, Patient Care Solutions | A | 6,861 | $0.00 | $0.00 |
| Mar 2, 2026 | Bankes Jeannette | CEO, Patient Care Solutions | A | 18,038 | $0.00 | $0.00 |
| Mar 2, 2026 | Newcomb George A. | Chief Accounting Officer | A | 1,309 | $0.00 | $0.00 |
| Mar 2, 2026 | SACCARO JAMES | Chief Financial Officer | A | 12,475 | $0.00 | $0.00 |
| Mar 2, 2026 | SACCARO JAMES | Chief Financial Officer | A | 32,797 | $0.00 | $0.00 |
| Mar 2, 2026 | Jimenez Frank R | GC & Corporate Secretary | A | 28,697 | $0.00 | $0.00 |
| Mar 2, 2026 | Jimenez Frank R | GC & Corporate Secretary | A | 10,915 | $0.00 | $0.00 |
| Mar 2, 2026 | Arduini Peter J | President and CEO | A | 49,120 | $0.00 | $0.00 |
| Mar 2, 2026 | Arduini Peter J | President and CEO | A | 129,140 | $0.00 | $0.00 |
| Mar 2, 2026 | Rackliffe Philip | CEO, AVS | A | 9,356 | $0.00 | $0.00 |
| Mar 2, 2026 | Kass-Hout Taha | Chief Technology Officer | A | 34,847 | $0.00 | $0.00 |
| Mar 2, 2026 | O'Neill Kevin Michael | CEO, PDx | A | 17,218 | $0.00 | $0.00 |
| Feb 12, 2026 | Arduini Peter J | President and CEO | F | 33,445 | $79.20 | $2.6M |
| Feb 12, 2026 | Arduini Peter J | President and CEO | A | 74,908 | $0.00 | $0.00 |
| Feb 12, 2026 | SACCARO JAMES | Chief Financial Officer | F | 8,570 | $79.20 | $678.7K |
| Feb 12, 2026 | SACCARO JAMES | Chief Financial Officer | A | 22,610 | $0.00 | $0.00 |
| Feb 12, 2026 | Jimenez Frank R | GC & Corporate Secretary | F | 8,357 | $79.20 | $661.9K |
| Feb 12, 2026 | Jimenez Frank R | GC & Corporate Secretary | A | 22,078 | $0.00 | $0.00 |
| Feb 12, 2026 | O'Neill Kevin Michael | CEO, PDx | F | 3,261 | $79.20 | $258.3K |
| Feb 12, 2026 | O'Neill Kevin Michael | CEO, PDx | A | 6,938 | $0.00 | $0.00 |
| Feb 12, 2026 | Rott Roland | CEO, Imaging | F | 3,943 | $79.20 | $312.3K |
| Feb 12, 2026 | Rott Roland | CEO, Imaging | A | 7,885 | $0.00 | $0.00 |
| Feb 12, 2026 | Rackliffe Philip | CEO, AVS | F | 1,174 | $79.20 | $93.0K |
| Feb 12, 2026 | Rackliffe Philip | CEO, AVS | A | 3,154 | $0.00 | $0.00 |
6 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 5 neutral. Avg impact: 3.3/10.
NEUTRAL
CLUSTER
2/10
Two independent directors made modest open-market purchases totaling $163K in GEHC, while the CEO of
May 19, 2026
NEUTRAL
CLUSTER
4/10
GE HealthCare insiders, including director H. Lawrence Culp Jr. ($5.0M), CEO Peter Arduini ($250K),
May 12, 2026
NEUTRAL
8-K
2/10
GE HealthCare filed an 8-K reporting the results of its May 7, 2026 annual shareholder meeting and t
May 11, 2026
NEUTRAL
CLUSTER
2/10
Three top executives (CEO, CFO, GC) at GE HealthCare made open-market purchases totaling ~$556K, rep
May 1, 2026
BEARISH
8-K
7/10
GE HealthCare reported Q1 2026 revenue of $5.13B (+7.4% YoY) and GAAP diluted EPS of $0.85, down fro
Apr 29, 2026
NEUTRAL
DEFA14A
3/10
GE HealthCare Technologies Inc. has filed its 2026 Definitive Proxy Statement (DEFA14A), which outli
Mar 19, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (67% buy). Based on 27 analysts: 8 strong buy, 10 buy, 9 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$79.72 mean target
+20.8% upside
Strong Buy (1.83)
$65.00 Low
$98.00 High
| Metric | Value |
|---|---|
| Current Price | $66.01 |
| Target Low | $65.00 |
| Target Mean | $79.72 |
| Target Median | $80.00 |
| Target High | $98.00 |
| # Analysts | 18 |
| Recommendation | Strong Buy (1.83) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$1.03 | $1.01 | $1.05 | -2.7% | -6.4% | 0↑ 14↓ | $5.3B | 5.1% | 14 |
| Next Q 2026-09-30 |
$1.24 | $1.19 | $1.30 | 16.1% | -0.4% | 4↑ 8↓ | $5.4B | 5.1% | 14 |
| Current FY 2026-12-31 |
$4.87 | $4.69 | $4.96 | 6.2% | -2.2% | 0↑ 19↓ | $21.8B | 5.6% | 19 |
| Next FY 2027-12-31 |
$5.37 | $4.56 | $5.62 | 10.2% | -2.3% | 1↑ 18↓ | $22.8B | 4.6% | 19 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.032 | |
| 7d ago | $1.032 | -0.001 |
| 30d ago | $1.102 | -0.070 |
| 60d ago | $1.166 | -0.134 |
| 90d ago | $1.168 | -0.137 |
13 analyst firms have rated this stock: 1 upgrades, 2 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 21, 2026 | UBS | UPGRADE | Sell | Neutral |
| Apr 30, 2026 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Apr 30, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Apr 30, 2026 | Goldman Sachs | DOWNGRADE | Buy | Neutral |
| Apr 30, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Apr 30, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Apr 30, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Apr 29, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Apr 21, 2026 | BTIG | REITERATE | Buy | Buy |
| Apr 17, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Apr 13, 2026 | Mizuho | MAINTAIN | Outperform | Outperform |
| Apr 9, 2026 | Goldman Sachs | MAINTAIN | Buy | Buy |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Mar 19, 2026 | BTIG | REITERATE | Buy | Buy |
| Mar 11, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Feb 9, 2026 | BTIG | REITERATE | Buy | Buy |
| Feb 6, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 5, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Feb 5, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Feb 5, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Feb 5, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Feb 4, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jan 30, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Jan 15, 2026 | UBS | DOWNGRADE | Neutral | Sell |
| Jan 7, 2026 | Stifel | MAINTAIN | Buy | Buy |
| Jan 5, 2026 | B of A Securities | MAINTAIN | Neutral | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 8 | 10 | 9 | 0 | 0 | 67% | |
| May 1, 2026 | 8 | 10 | 9 | 1 | 0 | 64% | |
| Apr 1, 2026 | 8 | 11 | 8 | 1 | 0 | 68% | |
| Mar 1, 2026 | 8 | 11 | 8 | 1 | 0 | 68% | |
| Feb 1, 2026 | 8 | 11 | 8 | 1 | 0 | 68% | |
| Jan 1, 2026 | 8 | 11 | 9 | 0 | 0 | 68% |
Strong BuyBuyHoldSellStrong Sell
3 members of Congress traded this stock: 1 buys, 2 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | May 13, 2026 (31d) |
| Mar 25, 2026 | Terri Sewell | D | HOUSE | SELL | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | Apr 21, 2026 (28d) |
| Mar 23, 2026 | Warren Davidson | R | HOUSE | SELL | $1,001 - $15,000 | GE HEALTHCARE TECHNOLOGI INC | Mar 26, 2026 (4d) |
63°
Warm
Bearish
Neutral
Bullish
4 mentions
2 bullish
0 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 16, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 16, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 11, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
| May 11, 2026 | 1 | 44° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
How to Find History of Shares
▲ 1
💬 0
⚡ 0.5
GEHC: insider Larry Culp just dropped $5M. Deep value?
▲ 1
💬 1
⚡ 0.5
Jun 8, 2026
short_volume
Short Volume: GEHC — 65.5% short (1.4M / 2.1M)
Short: 1,353,718 | Exempt: 898 | TRF Vol: 2,065,798 | Short Ratio: 65.5% | Off-exchange volume (dark pool + OTC)
May 18, 2026
dark_pool
Dark Pool: GEHC — 7.9M shares, 104,675 trades
Week starting 2026-05-18. Total ATS volume: 7,866,710 shares across 104,675 trades.
May 11, 2026
dark_pool
Dark Pool: GEHC — 6.7M shares, 107,120 trades
Week starting 2026-05-11. Total ATS volume: 6,671,096 shares across 107,120 trades.
May 4, 2026
dark_pool
Dark Pool: GEHC — 8.2M shares, 104,130 trades
Week starting 2026-05-04. Total ATS volume: 8,219,010 shares across 104,130 trades.
Apr 29, 2026
earnings_calendar
GEHC Q1 2026 Earnings Scheduled — 2026-04-29
Apr 28, 2026
short_volume
Short Volume: GEHC — 65.7% short (1.4M / 2.1M)
Short: 1,394,896 | Exempt: 23 | TRF Vol: 2,122,704 | Short Ratio: 65.7% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
dark_pool
Dark Pool: GEHC — 14.8M shares, 170,919 trades
Week starting 2026-04-27. Total ATS volume: 14,776,933 shares across 170,919 trades.
Apr 24, 2026
short_volume
Short Volume: GEHC — 59.4% short (0.7M / 1.2M)
Short: 739,346 | Exempt: 0 | TRF Vol: 1,243,675 | Short Ratio: 59.4% | Off-exchange volume (dark pool + OTC)
Apr 23, 2026
short_volume
Short Volume: GEHC — 62.7% short (0.7M / 1.2M)
Short: 730,143 | Exempt: 875 | TRF Vol: 1,164,818 | Short Ratio: 62.7% | Off-exchange volume (dark pool + OTC)
Apr 22, 2026
short_volume
Short Volume: GEHC — 65.4% short (0.9M / 1.3M)
Short: 881,912 | Exempt: 1,023 | TRF Vol: 1,347,526 | Short Ratio: 65.4% | Off-exchange volume (dark pool + OTC)
Apr 20, 2026
dark_pool
Dark Pool: GEHC — 4.1M shares, 70,901 trades
Week starting 2026-04-20. Total ATS volume: 4,078,131 shares across 70,901 trades.
Apr 16, 2026
short_volume
Short Volume: GEHC — 74.1% short (0.6M / 0.8M)
Short: 564,683 | Exempt: 564 | TRF Vol: 762,089 | Short Ratio: 74.1% | Off-exchange volume (dark pool + OTC)
Apr 15, 2026
short_volume
Short Volume: GEHC — 69.5% short (0.7M / 1.0M)
Short: 688,077 | Exempt: 0 | TRF Vol: 989,873 | Short Ratio: 69.5% | Off-exchange volume (dark pool + OTC)
Apr 14, 2026
short_volume
Short Volume: GEHC — 65.7% short (0.4M / 0.6M)
Short: 422,598 | Exempt: 2,997 | TRF Vol: 642,907 | Short Ratio: 65.7% | Off-exchange volume (dark pool + OTC)
Apr 13, 2026
short_volume
Short Volume: GEHC — 65.4% short (0.4M / 0.6M)
Short: 420,700 | Exempt: 844 | TRF Vol: 643,490 | Short Ratio: 65.4% | Off-exchange volume (dark pool + OTC)